Move a Key Commercialization CatalystDENVER, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or “the Company”) announced a major milestone in the commercialization of its recombinant spider silk platform, confirming that it is now fulfilling an order for customized spider silk yarns from a globally recognized performance sports apparel brand, as part of a confidential pilot development program to create a special product, which is under strict confidentiality until ...